Clinical trials
Recruiting Breast Neoplasms trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Celcuity Inc | 1 |
| Daiichi Sankyo | 1 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Greenwich LifeSciences, Inc. | 1 |
| Jules Bordet Institute | 1 |
| National Institute of Oncology, Hungary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 20 |
| Neoplasm Metastasis | 3 |
| Breast Neoplasms, Male | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Disease Progression | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Neoplasm, Residual | 1 |
| Ovarian Neoplasms | 1 |
| Pathologic Complete Response | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.